Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

National Healthcare Properties (HLTC) Cash from Financing Activities (2016 - 2025)

Historic Cash from Financing Activities for National Healthcare Properties (HLTC) over the last 13 years, with Q3 2025 value amounting to -$7.8 million.

  • National Healthcare Properties' Cash from Financing Activities fell 13114.29% to -$7.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$64.4 million, marking a year-over-year decrease of 31543.61%. This contributed to the annual value of -$1.3 million for FY2024, which is 10240.66% down from last year.
  • Latest data reveals that National Healthcare Properties reported Cash from Financing Activities of -$7.8 million as of Q3 2025, which was down 13114.29% from -$29.4 million recorded in Q2 2025.
  • In the past 5 years, National Healthcare Properties' Cash from Financing Activities registered a high of $82.5 million during Q3 2021, and its lowest value of -$78.5 million during Q2 2021.
  • For the 5-year period, National Healthcare Properties' Cash from Financing Activities averaged around $1.1 million, with its median value being -$4.5 million (2025).
  • Per our database at Business Quant, National Healthcare Properties' Cash from Financing Activities skyrocketed by 167031.93% in 2022 and then crashed by 202223.68% in 2025.
  • National Healthcare Properties' Cash from Financing Activities (Quarter) stood at $1.4 million in 2021, then surged by 1670.32% to $24.4 million in 2022, then tumbled by 64.97% to $8.5 million in 2023, then plummeted by 365.42% to -$22.7 million in 2024, then soared by 65.63% to -$7.8 million in 2025.
  • Its Cash from Financing Activities was -$7.8 million in Q3 2025, compared to -$29.4 million in Q2 2025 and -$4.5 million in Q1 2025.